Entering text into the input field will update the search result below

Carlyle Group takes out Albany Molecular Research for $21.75/share; +9% premarket

Jun. 06, 2017 8:35 AM ETAlbany Molecular Research, Inc. (AMRI) StockBy: Douglas W. House, SA News Editor
  • Affiliates of The Carlyle Group and GTCR LLC have agreed to acquire Albany Molecular Research (NASDAQ:AMRI) for $21.75 per share. Albany's board has unanimously endorsed the deal.
  • The transaction will be financed with debt and equity.
  • Shares are up 9% premarket on robust volume.
  • Previously: Albany Molecular exploring sale; shares up 8% (April 7)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AMRI--
Albany Molecular Research, Inc.